3 ASX 300 shares just upgraded by top brokers

ASX 300 shares have opened stronger amid various broker updates today.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • ASX 300 shares have opened stronger amid various broker updates today
  • Analysts have raised their ratings on Webjet and Sigma Health shares 
  • However, there are diverging views on ASX Ltd shares 

S&P/ASX 300 (ASX: XKO) shares opened stronger amid various broker updates today.

ASX 300 shares are currently up 0.21% at the time of writing.

Let's see what's news with the ASX experts.

a man sits in unhappy contemplation staring at his computer on his desk in a home environment, propping his chin on his hand.

Image source: Getty Images

Brokers alter ratings on this trio of ASX 300 shares

According to The Australian, analysts are split on the virtue of investing in the Australian share market operator ASX Ltd (ASX: ASX) today.

This follows the company releasing an update at its investor day yesterday.

At the event, ASX management increased its cost guidance and lowered its dividend payout ratio for FY24.

Despite this, investment group CSLA has raised its rating on ASX shares to accumulate with a $65.50 price target.

ASX shares are trading at $61.12 at the time of writing, implying a potential upside of 7% for new investors who buy today.

However, other brokers have turned on the stock.

UBS has cut ASX shares to a sell rating with a 16% target price reduction to $59. Jarden Securities has cut its rating to neutral with a $64.85 price target.

Morgan Stanley has cut its price target by 36% to $62.40. Citi has also cut its price target on ASX shares by 9% to $64.

Turning to ASX 300 healthcare shares, Shaw and Partners has raised its rating on Sigma Healthcare Ltd (ASX: SIG) shares to a buy.

This follows the stock's 22% surge yesterday after the pharmacy operator and supplier announced a new $3 billion deal with Chemist Warehouse.

The companies also renewed a contract that was generating approximately $1 billion in sales for Sigma.

As part of the deal, Chemist Warehouse will receive a 10.7% stake in Sigma Health.

Sigma Health shares are up another 1.55% this morning to 78.7 cents.

In other news, Jarden Securities has raised its rating on ASX 300 travel share Webjet Limited (ASX: WEB) to overweight.

Webjet shares also opened stronger but slipped back to trade even at the time of writing at $7.22 a share.

Conversely, First Sentier appears to believe it's time to reduce Webjet shares.

A change in substantial holding notice posted yesterday shows the investment group reduced its stake in the online travel agency from 12.78% to 11.73% last Friday.

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A man holding a cup of coffee puts his thumb up and smiles with a laptop open.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

A man in a business suit rides a graphic image of an arrow that is rebounding on a graph.
Broker Notes

Down 43% this week, are Cochlear shares now the best bargain buy of the year?

A leading analyst believes the historic selloff in Cochlear shares could present a unique buying opportunity.

Read more »

A smiling woman at a hardware shop selects paint colours from a wall display.
Broker Notes

Wesfarmers shares: Buy, hold or sell?

A leading analyst delivers his verdict on Wesfarmers shares.

Read more »

Businessman working and using Digital Tablet new business project finance investment at coffee cafe.
Broker Notes

Buy, hold, sell: Cochlear, CSL, and DroneShield shares

Are these hugely popular shares in the buy zone or not? Let's find out.

Read more »

Man with rocket wings which have flames coming out of them.
Broker Notes

These ASX 200 shares could rise ~40% to 80%

Brokers are predicting big returns for these top shares. Here's what you need to know.

Read more »

Person pointing at an increasing blue graph which represents a rising share price.
Broker Notes

2 ASX 200 stocks that could rise 50%

Morgans thinks the market is undervaluing these shares.

Read more »

Contented looking man leans back in his chair at his desk and smiles.
Broker Notes

Brokers name 3 ASX shares to buy right now

Here's why brokers are feeling bullish about these three shares this week.

Read more »

Dollar sign in yellow with a red falling arrow in front of a graph, symbolising a falling share price.
Broker Notes

6 ASX 200 shares downgraded by brokers this week

Brokers have reduced their ratings on TechnologyOne, Macquarie, 4DMedical, and others this week.

Read more »